AXQ Capital’s Exagen XGN Stock Holding History

AXQ Capital’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$130K	Sell	27,948 -6,645	-19%	-$25K	0.01%	780
2026 Q1	$104K	Buy	+34,593	New	+$134K	0.01%	864

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

AXQ Capital's XGN Position: Q2 2026 in Review

AXQ Capital reduced its Exagen (XGN) stake by 19% in Q2 2026, selling an estimated $25K and leaving 27,948 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #780.

AXQ Capital first reported a position in XGN in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

AXQ Capital held 27,948 shares of Exagen worth $130K as of Q2 2026.
AXQ Capital sold 6,645 Exagen shares in Q2 2026, an estimated $25K.
Exagen made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #780 holding.
AXQ Capital first reported a position in Exagen in Q1 2026 and has held it in 2 quarters since.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.